ABSTRACT Baroreceptor sensitivity, reflected by the slope of the linear regression of the electrocardiographic R-R interval on the rise of systolic blood pressure after injection of phenylephrine, was significantly lower in 27 patients with chronic obstructive pulmonary disease (4-67 + 2-67) than in 10 normal subjects (12.07 + 3 3) of comparable age (p < 0 001). In 20 patients in whom right heart catheterisation was performed, pulmonary artery pressure was inversely related to baroreflex sensitivity (r = -0-603, p < 0 01). Independent variables such as arterial Po2, Pco2, and mean pulmonary artery pressure were examined in order to assess their ability to predict baroreflex sensitivity. The independent variable that made the most significant contribution was mean pulmonary artery pressure. It seems that the attenuation of baroreflex response in patients with chronic obstructive pulmonary disease is caused mainly by pulmonary hypertension and partly by the central effects of hypoxia and hypercapnia.
Dysfunction of the baroreceptor reflex in man has been described in established' 2 and borderline hypertension,2 3 in uraemic patients,4 and in patients with heart disease.5 There has been little study of baroreceptor function in patients with chronic obstructive pulmonary disease (COPD).5 In our study the sensitivity of the baroreceptor reflex in patients with COPD is compared with that in agematched controls.
Methods
Twenty-seven male patients with COPD and 10 normal subjects were studied. Both groups had comparable ages; mean age was 58 3 ± 8-7 in COPD patients and 55-1 ± 9 1 in normal subjects. No Baroreflex sensitivity was estimated by relating the increase in pulse interval (expressed as R-R interval on electrocardiography, in ms) to the transient rise in systolic blood pressure in mmHg induced by the intravenous injection of a phenylephrine bolus. Plotting R-R interval against rise in systolic blood pressure results in a linear relationship, the slope of which is a measure of baroreflex sensitivity. The steeper the slope the greater the sensitivity of the reflex. The influence of sinus arrhythmia on the analysis was minimised by excluding beats occurring during inspiration from the calculation.
All subjects were studied in the supine position The results of our study indicate that patients with COPD have reduced responsiveness of the baroreceptor reflex to transient rise of blood pressure as assessed by the prolongation of the R-R interval. The method used in this study was developed by Smith et al. 8 In the original method, angiotensin was used as the pressor agent, but because of the direct cardiac action of this drug9 and the late tachycardia, which probably results from central stimulation of the sympathetic pathway,10 we decided to substitute phenylephrine. The bradycardia produced after phenylephrine injection is reflex in nature since a direct effect of the drug on the heart has been excluded.'112
The sensitivity of the heart rate-blood pressure reflex depends on the inter-relation of autonomic nervous activity affecting the heart and it falls with a decline in vagal tone.'314 Comparison of subjects' resting heart rates can be used for detection of gross variations in autonomic tone. 2 We did not find any statistically significant difference in control heart rate between our control subjects and patients with COPD to explain the attenuation of baroreflex sensitivity in patients.
Since age2 can affect baroreceptor sensitivity, normal subjects at ages comparable to those of patients with COPD were chosen as controls in our study. In spite of the observations that bed rest and physical activity do not appear to alter baroreceptor responsiveness, care has been taken to ensure that our patients avoided excessive bed rest and immobilisation. '7 There is some evidence that receptors in the aortic arch area are of greater importance than those in the carotid sinus in the reflex regulation of the heart.'5
The baroreceptors lie within the arterial wall and they respond to deformation brought about by a change in transmural pressure. If the arterial wall is stiffer than normal it may be that the receptors will be splinted and protected to some extent from the arterial pressure and will respond to a given pressure rise with a reduced afferent nerve activity.'6 Most of our patients were old but we cannot see any reason for them to have more severe aortic degeneration than the age-matched control subjects since blood pressure was similar in both groups.
Eckberg et al'7 studying patients with heart disease, found a linear regression relating R-R interval to systolic pressure with a mean slope of 4f4 ms/mmHg and concluded that the baroreceptor abnormality reflected a profound abnormality in parasympathetic cardiovascular regulation in heart disease. Heart disease-induced changes in baroreceptor function could be important in the baroreceptor abnormality in some of our patients with COPD. According to our analysis mean pulmonary arterial pressure is the independent variable that makes the most significant contribution in attenuation of baroreflex function. Pulmonary artery pressure was elevated (> 22 mmHg) in 11 patients and all of these had a diminished baroreceptor slope. Four out of nine patients with normal pulmonary artery pressure had a remarkable attenuation of baroreceptor sensitivity (AR-R/IASAP < 5-6). It seems that pulmonary hypertension alone cannot explain the loss of baroreceptor sensitivity in all patients.
Hyperoxic hypercapnia has been shown to produce a resetting of the threshold in normal subjects without a change of the sensitivity of the reflex. '8 Patients with chronic lung disease also became hypotensive during lower body negative pressure with minimal reflex vasoconstriction of forearm vessels '9 in contrast with what happens in normal subjects, where during hypoxia arterial pressure is maintained despite the sudden "haemorrhage" by reflex vasoconstriction and tachycardia.20
In our patients with COPD the attenuation of baroreceptor sensitivity was more prominent in those with lower arterial Po2 and higher arterial Pco2. We are not aware of evidence that these gaseous stimuli have any effect on the baroreceptors themselves or on the afferent fibres passing from them. Likewise, no direct action of moderate changes in Pco2 or pH on the firing rate of pacemaker cells in the heart would be anticipated and probably therefore there would be no change in the sensitivity of the cardiac response to extrinsic neural influences.21 By exclusion, the attenuation of the baroreflex appears to be central.
The central sites might be multiple: chemical and electrical stimulation of the superficial medullary hydrogen ion (CO2) receptors is associated with circulatory as well as respiratory effects and the rise of blood pressure seen is more prominent than tachycardia.22
In conclusion, patients with chronic obstructive pulmonary disease have a blunted baroreceptor response to pharmacologically induced blood pressure changes partly related to pulmonary hypertension and partly to hypoxia and hypercapnia.
The role this dysfunction of the baroreceptor reflex plays in patients with COPD remains unknown.
The ability to alter heart rate constitutes an extremely important mechanism by which the cardiac output is adjusted. Changes in heart rate account in large measure for changes in cardiac output, alteration in stroke volume playing a far less important part.23
In patients with COPD the ability of stroke volume to rise is limited during exercise because of poor filling of the left ventricle,24 and when this limitation is combined with defective control of heart rate, it may contribute importantly to the inability to raise cardiac output appropriately, especially during exercise.
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